Eric K. Nicholson

Array ( [id] => 7499124 [patent_doc_number] => 20110262348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Selective targeting of intratumoral cells' [patent_app_type] => utility [patent_app_number] => 13/065794 [patent_app_country] => US [patent_app_date] => 2011-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21430 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262348.pdf [firstpage_image] =>[orig_patent_app_number] => 13065794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063875 [patent_doc_number] => 20110245090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/046485 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42841 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245090.pdf [firstpage_image] =>[orig_patent_app_number] => 13046485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778899 [patent_doc_number] => 20120041175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'NOVEL AUTOGRAPHY REGULATORS ATG14L AND RUBICON' [patent_app_type] => utility [patent_app_number] => 13/046428 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 45395 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041175.pdf [firstpage_image] =>[orig_patent_app_number] => 13046428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066185 [patent_doc_number] => 20110243930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/025008 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41550 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243930.pdf [firstpage_image] =>[orig_patent_app_number] => 13025008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245334 [patent_doc_number] => 08609614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'GBS toxin receptor compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 13/022357 [patent_app_country] => US [patent_app_date] => 2011-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12539 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13022357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110346 [patent_doc_number] => 20110189207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHODS FOR SOLUBLE ZALPHA11 CYTOKINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/021270 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58137 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189207.pdf [firstpage_image] =>[orig_patent_app_number] => 13021270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8650752 [patent_doc_number] => 20130036482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'METHOD FOR ASSESSMENT OF POTENTIAL FOR DEVELOPMENT OF DRAVET SYNDROME AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/574977 [patent_app_country] => US [patent_app_date] => 2011-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28927 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8955410 [patent_doc_number] => 08501180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Anti system ASC amino acid transporter 2 (ASCT2) antibody' [patent_app_type] => utility [patent_app_number] => 13/008532 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 56370 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13008532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958432 [patent_doc_number] => 20110182819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Methods and Compounds for Promoting Vessel Regression' [patent_app_type] => utility [patent_app_number] => 13/007202 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17249 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182819.pdf [firstpage_image] =>[orig_patent_app_number] => 13007202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566029 [patent_doc_number] => 20120328599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'INHIBITORS OF RECEPTOR TYROSINE KINASES (RTK) AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/519837 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 46949 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968925 [patent_doc_number] => 20110150824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Nutritional Composition for Improving the Mammalian Immune System' [patent_app_type] => utility [patent_app_number] => 12/977123 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13436 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150824.pdf [firstpage_image] =>[orig_patent_app_number] => 12977123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189705 [patent_doc_number] => 20110172114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/976029 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41597 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172114.pdf [firstpage_image] =>[orig_patent_app_number] => 12976029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663612 [patent_doc_number] => 20110312881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'BIFUNCTIONAL POLYPEPTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF METABOLIC AND CARDIOVASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 12/975054 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 77014 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312881.pdf [firstpage_image] =>[orig_patent_app_number] => 12975054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8720195 [patent_doc_number] => 20130071412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'METHODS AND COMPOSITIONS FOR STABLE LIQUID DRUG FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/517024 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10436 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6008097 [patent_doc_number] => 20110060128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'PROCESS FOR THE PURIFICATION OF INTERLEUKIN-4 AND ITS MUTEINS' [patent_app_type] => utility [patent_app_number] => 12/945829 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12111 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060128.pdf [firstpage_image] =>[orig_patent_app_number] => 12945829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6185239 [patent_doc_number] => 20110124081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'NUCLEAR FACTOR OF ACTIVATED T CELLS RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/939385 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13334 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124081.pdf [firstpage_image] =>[orig_patent_app_number] => 12939385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070637 [patent_doc_number] => 20110045487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHODS OF DIAGNOSING MYELODYSPLASTIC SYNDROME (MDS) OR LEUKEMIA USING NUCLEIC ACIDS OR FRAGMENTS ENCODING FLT3 KINASE' [patent_app_type] => utility [patent_app_number] => 12/938712 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7030 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045487.pdf [firstpage_image] =>[orig_patent_app_number] => 12938712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024281 [patent_doc_number] => 20110052607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'METHODS OF DIAGNOSING MYELODYSPLASTIC SYNDROME (MDS) OR LEUKEMIA USING NUCLEIC ACIDS OR FRAGMENTS ENCODING FLT3 KINASE' [patent_app_type] => utility [patent_app_number] => 12/938629 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7028 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052607.pdf [firstpage_image] =>[orig_patent_app_number] => 12938629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070638 [patent_doc_number] => 20110045488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHODS OF DIAGNOSING MYELODYSPLASTIC SYNDROME (MDS) OR LEUKEMIA USING NUCLEIC ACIDS OR FRAGMENTS ENCODING FLT3 KINASE' [patent_app_type] => utility [patent_app_number] => 12/938723 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7030 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045488.pdf [firstpage_image] =>[orig_patent_app_number] => 12938723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007430 [patent_doc_number] => 20110059461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'METHODS OF DIAGNOSING MYELODYSPLASTIC SYNDROME (MDS) OR LEUKEMIA USING NUCLEIC ACIDS OR FRAGMENTS ENCODING FLT3 KINASE' [patent_app_type] => utility [patent_app_number] => 12/938617 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7030 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059461.pdf [firstpage_image] =>[orig_patent_app_number] => 12938617 [rel_patent_id] =>[rel_patent_doc_number] =>)